Cargando…

Headache determines quality of life in idiopathic intracranial hypertension

BACKGROUND: The effect of idiopathic intracranial hypertension (IIH) on quality of life (QOL) is poorly understood. Our objectives were to compare QOL in IIH to the normal UK population; to investigate QOL changes with treatment of IIH, using a weight loss intervention, and to determine which clinic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mulla, Yasmeen, Markey, Keira A, Woolley, Rebecca L, Patel, Smitaa, Mollan, Susan P, Sinclair, Alexandra J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Milan 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4436432/ https://www.ncbi.nlm.nih.gov/pubmed/25982204 http://dx.doi.org/10.1186/s10194-015-0521-9

Ejemplares similares

EHMTI-0304. Headache determines quality of life in idiopathic intracranial hypertension
por: Sinclair, A, et al.
Publicado: (2014)

Therapeutic lumbar puncture for headache in idiopathic intracranial hypertension: Minimal gain, is it worth the pain?
por: Yiangou, Andreas, et al.
Publicado: (2018)

Advances in the understanding of headache in idiopathic intracranial hypertension
por: Mollan, Susan P., et al.
Publicado: (2019)

European Headache Federation guideline on idiopathic intracranial hypertension
por: Hoffmann, Jan, et al.
Publicado: (2018)

A practical approach to, diagnosis, assessment and management of idiopathic intracranial hypertension
por: Mollan, Susan P, et al.
Publicado: (2014)

What Do Transgender Patients Teach Us About Idiopathic Intracranial Hypertension?
por: Hornby, Catherine, et al.
Publicado: (2017)

Characterising the patient experience of diagnostic lumbar puncture in idiopathic intracranial hypertension: a cross-sectional online survey
por: Scotton, William J, et al.
Publicado: (2018)

Increased systemic and adipose 11β-HSD1 activity in idiopathic intracranial hypertension
por: Westgate, Connar S J, et al.
Publicado: (2022)

Intracranial pressure directly predicts headache morbidity in idiopathic intracranial hypertension
por: Mollan, S. P., et al.
Publicado: (2021)

The expanding burden of idiopathic intracranial hypertension
por: Mollan, Susan P., et al.
Publicado: (2018)

Erenumab for headaches in idiopathic intracranial hypertension: A prospective open‐label evaluation
por: Yiangou, Andreas, et al.
Publicado: (2020)

Evaluation and management of adult idiopathic intracranial hypertension
por: Mollan, Susan P, et al.
Publicado: (2018)

Association of Amount of Weight Lost After Bariatric Surgery With Intracranial Pressure in Women With Idiopathic Intracranial Hypertension
por: Mollan, Susan P., et al.
Publicado: (2022)

Headache, Opiate Use, and Prescribing Trends in Women With Idiopathic Intracranial Hypertension: A Population-Based Matched Cohort Study
por: Adderley, Nicola Jaime, et al.
Publicado: (2022)

Emerging themes in idiopathic intracranial hypertension
por: Grech, Olivia, et al.
Publicado: (2020)

Novel advances in monitoring and therapeutic approaches in idiopathic intracranial hypertension
por: Mitchell, James L., et al.
Publicado: (2019)

Nuclear Magnetic Resonance Spectroscopy Metabolomics in Idiopathic Intracranial Hypertension to Identify Markers of Disease and Headache
por: Grech, Olivia, et al.
Publicado: (2022)

Randomised controlled trial of bariatric surgery versus a community weight loss programme for the sustained treatment of idiopathic intracranial hypertension: the Idiopathic Intracranial Hypertension Weight Trial (IIH:WT) protocol
por: Ottridge, Ryan, et al.
Publicado: (2017)

Calcitonin gene related peptide monoclonal antibody treats headache in patients with active idiopathic intracranial hypertension
por: Yiangou, Andreas, et al.
Publicado: (2020)

Systemic and adipocyte transcriptional and metabolic dysregulation in idiopathic intracranial hypertension
por: Westgate, Connar S.J., et al.
Publicado: (2021)

Negative impact of COVID-19 lockdown on papilloedema and idiopathic intracranial hypertension
por: Thaller, Mark, et al.
Publicado: (2021)

Managing idiopathic intracranial hypertension in pregnancy: practical advice
por: Thaller, Mark, et al.
Publicado: (2022)

Metabolic Concepts in Idiopathic Intracranial Hypertension and Their Potential for Therapeutic Intervention
por: Hornby, Catherine, et al.
Publicado: (2018)

Reviewing the Recent Developments in Idiopathic Intracranial Hypertension
por: Virdee, Jasvir, et al.
Publicado: (2020)

Assessing the Efficacy and Safety of an 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibitor (AZD4017) in the Idiopathic Intracranial Hypertension Drug Trial, IIH:DT: Clinical Methods and Design for a Phase II Randomized Controlled Trial
por: Markey, Keira Annie, et al.
Publicado: (2017)

Idiopathic intracranial hypertension, hormones, and 11β-hydroxysteroid dehydrogenases
por: Markey, Keira A, et al.
Publicado: (2016)

Evolving evidence in adult idiopathic intracranial hypertension: pathophysiology and management
por: Mollan, Susan P, et al.
Publicado: (2016)

Current Perspectives on Idiopathic Intracranial Hypertension without Papilloedema
por: Mollan, Susan P., et al.
Publicado: (2021)

Idiopathic intracranial hypertension: Evaluation of births and fertility through the Hospital Episode Statistics dataset
por: Thaller, Mark, et al.
Publicado: (2022)

Evolving Evidence in Idiopathic Intracranial Hypertension
por: Mollan, Susan P., et al.
Publicado: (2021)

11β-Hydroxysteroid dehydrogenase type 1 inhibition in idiopathic intracranial hypertension: a double-blind randomized controlled trial
por: Markey, Keira, et al.
Publicado: (2020)

Segmentation error in spectral domain optical coherence tomography measures of the retinal nerve fibre layer thickness in idiopathic intracranial hypertension
por: Aojula, Anuriti, et al.
Publicado: (2018)

Negative impact of COVID-19 lockdown on papilloedema and idiopathic intracranial hypertension
por: Thaller, M., et al.
Publicado: (2021)

Evaluation of diurnal and postural intracranial pressure employing telemetric monitoring in idiopathic intracranial hypertension
por: Mitchell, James L, et al.
Publicado: (2022)

A unique androgen excess signature in idiopathic intracranial hypertension is linked to cerebrospinal fluid dynamics
por: O’Reilly, Michael W., et al.
Publicado: (2019)

Longitudinal prospective cohort study evaluating prognosis in idiopathic intracranial hypertension patients with and without comorbid polycystic ovarian syndrome
por: Thaller, Mark, et al.
Publicado: (2023)

Cognitive performance in idiopathic intracranial hypertension and relevance of intracranial pressure
por: Grech, Olivia, et al.
Publicado: (2021)

Association Between Idiopathic Intracranial Hypertension and Risk of Cardiovascular Diseases in Women in the United Kingdom
por: Adderley, Nicola J., et al.
Publicado: (2019)

Obstructive sleep apnoea in women with idiopathic intracranial hypertension: a sub-study of the idiopathic intracranial hypertension weight randomised controlled trial (IIH: WT)
por: Yiangou, Andreas, et al.
Publicado: (2021)

What are the research priorities for idiopathic intracranial hypertension? A priority setting partnership between patients and healthcare professionals
por: Mollan, Susan, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_1asoicesikb5veae3m77tdajis